Doctor profile · Federal record
Dr. Ivan Batlle, MD
Ophthalmology Physician (CMS: Ophthalmology) · Ophthalmology Physician · Ophthalmology Physician · Ophthalmology Physician · Ophthalmology Physician · Retina Specialist (Ophthalmology) Physician · Retina Specialist (Ophthalmology) Physician · Retina Specialist (Ophthalmology) Physician · Retina Specialist (Ophthalmology) Physician · Retina Specialist (Ophthalmology) Physician · Lenexa, KS
- NPI 1073510962
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 41 yrs in practice
- Licensed in 5 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8600 Quivira RD Ste 100
Lenexa, KS 662152857
(913) 831-7400
fax (913) 831-7409
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- September 1, 2022
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State licenses (6)
- Kansas #04-31680 · Mississippi #16323 · Missouri #2005041174 · Texas #M9839 · Louisiana #MD.08085R · Kansas #0431680
- Medicaid (2)
- KS #200602400A · MO #204182109
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1073510962. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
17,171
Distinct HCPCS
10
Medicare allowed
$2,408,726
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 8,160 | 29 | $37 | |
92134 |
Imaging of retina | 1,917 | 733 | $38 | |
J0178 |
Injection, aflibercept, 1 mg | 1,372 | 151 | $869 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,275 | 791 | $120 | |
67028 |
Injection of drug into eye | 1,249 | 346 | $118 | |
92250 |
Photography of the retina | 841 | 686 | $34 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 698 | 30 | $225 | |
J3590 |
Unclassified biologics | 397 | 100 | $95 | |
J7312 |
Injection, dexamethasone, intravitreal implant, 0.1 mg | 336 | 17 | $199 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 272 | 272 | $157 |
In context: peer comparison
Among 5 peers in Lenexa Ophthalmology Physician, average services per provider: 1,116. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$2,621
Transactions
26
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| EyePoint Pharmaceuticals US, INC. | 5 | $2,135.46 | |
| Regeneron Healthcare Solutions, INC. | 8 | $223.32 | |
| Genentech USA, INC. | 4 | $77.01 | |
| Alimera Sciences, INC. | 3 | $65.40 | |
| Apellis Pharmaceuticals, INC. | 2 | $46.11 | |
| Abbvie INC. | 2 | $35.24 | |
| Ani Pharmaceuticals, INC. | 1 | $22.95 | |
| Dompe US, INC. | 1 | $15.54 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
435
Patients
218
Total drug cost
$9,284
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 175 | 107 | $5,778 |
| Ofloxacin | Generic | 91 | 74 | $1,301 |
| Timolol Maleate | Generic | 62 | 17 | $597 |
| Ketorolac Tromethamine | Generic | 27 | 20 | $606 |
| Latanoprost | Generic | 25 | 0 | $269 |
| Brimonidine Tartrate | Generic | 22 | 0 | $203 |
| Diclofenac Sodium | Generic | 11 | 0 | $164 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 11 | 0 | $101 |
| Moxifloxacin (Moxifloxacin Hcl) | Brand | 11 | 0 | $264 |
Frequently asked questions
What is Dr. Ivan Batlle's medical specialty?
Dr. Ivan Batlle practices Ophthalmology Physician in Lenexa, KS.
Where does Dr. Ivan Batlle practice?
Dr. Ivan Batlle practices at 8600 Quivira RD Ste 100, Lenexa, KS 662152857. Office phone: 9138317400.
What is Dr. Ivan Batlle's NPI?
Dr. Ivan Batlle's National Provider Identifier (NPI) is 1073510962, issued by NPPES.
Does Dr. Ivan Batlle accept Medicare assignment?
Yes. Dr. Ivan Batlle accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ivan Batlle commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection, aflibercept, 1 mg (HCPCS J0178). Source: CMS Medicare Physician & Other Practitioners file.